This is the authors' abstract. We don't add key points for this paper.
Microreactors have shown their ability to improve chemical processes and routes; however, their integration into chemical production processes depends not only on technical advances. Cost issues and productions logistics play a crucial role, too, and are highlighted with two different case studies. Economical drivers for the pharmaceutical industry are described with emphasis on future development of microprocess engineering.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Roberge et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: